Studies on the Conversion of Carbon-14 Dioxide into Glutamic Acid in Nicotiana Rustica L. and On the Hormonal Control of Pyruvate-2-�?c Metabolism in Rat Liver by Burns, Linda Cox
STUDIES ON THE CONVERSION OF C.ARBON-14 DIOXIDE 
INTO GLUTAMIC ACID IN NICOTIANA RUSTICA f• AND 
ON THE HORMONAL CONTROL OF PYRUVATE-2-14c 
METABOLISM IN RAT LIVER 
By 
LINDA COX·BURNS 
Bachelor of Arts 
University of Arkansas 
FaJ"etteville, Arkansas 
1964 
Submitted to the faculty of the Graduate College 
of the Oklahoma State University 
in partial fulfillment of the requirements 
for the degree of 






JAN 9 1968 
STUDIES ON THE CONVERSION OF CARBON-14 .· DIOXIDE 
ON THE HORMONAL CONTROL OF PYRUVATE-2-140 




Dean of the Graduate College 
858371 
ii 
I wish to thank:Dr. Ro~r Eo Koeppe tor.serving as research advise;r. 
during these studies and'Drs. Robert M. O'Neal and Sh~ad K. Meghal for 
their valuable counsel and assistance. 
I also wish to express appreciation to Drso Kurt E. Ebner and 
George R. Waller for reading the m~uscript and offering suggestions 
for its improvement~ 
Sp~cial thanks are due 11\Y husband, Mike, for his assistance in 
prepari~ this thesiso 
I a.rn 1 indebted to the Department of Biochemt,tpy for financial sup-
\ ' ,, 
port and facilities during these i~vestigations. 
iii. 
TABLE OF CQlffEN'11S 
PART I 
Chapter Page 
I. INTRODUCTION. 0 0 0 O O O • 0 0 •• e O o. • • 0 • 0 0 0 e • 0 
II. EXPERI~AL. o • • o o • • • o • • o • o .• • • • • • • o • • ~ 
A. Isolation Procedures • • • • 0 • 0 • 0 • • • • • • • e 
B. Counting Techniques• • • • • • • • • • • • • • • • • e 
c.: Degradation Procedures • • • • • • • • • • • • • • 0 19 
III. RESULTS AND DISCUSSION. • • • • • • • • • • • • • • • • • • 0 
IV. SUMMARY• • • • • • 0 • e •••• 0 0 0 0 e O O •. 0 0 • 0 • 0 
A SELECTED BIBLIOGRAPHY. •. • • • • • • • • • • • • • • • • •• o • • 2if1 
PART II 
I. INTRODUCTION •.••• • •••• ···• o •••• o • o • o • • • • o 24. 
II• EXPER.IMENTALo o o o • o o o •· o • o o • o o o o o • o • o o o jQ 
A. Isolation and ASSSJ' of Blood Glucoae O O O O O O O O ao 
B. Animal Experiments •• o • • o ••• o • • • • •• • 312 
1. Changes in Blood Glucose Levels with Gluoagon 
Ad.ministration •• o ••••••••••••• 3~ 
2. Isotope Experiments. • • •••• o •• • •••• 33 
c. Counting Techniques and Degradation Procedures o • • 31 
III. RESULTS ANDDISCUSSION. • • • • • • • • • • • • • • • • • • • 3i1-
IV. SUMMARY •••••• • o •••• • •••.• • o ••••• • • • 44: 
A SELECTED BIBLIOGRAPHY. • • • o • .. • • • • • • • • • • • • o • • • 45 





LIST OF TAI;!LES 
PART I 
Labeling in Leaf Amino Acids of Nicotiana Rustica !!,o 
after Exposure to 14qo20 .... o .... o. o " " o o " o 
I 
Derivation of Glutamate Carbon Atoms o 0 0 0 0 0 0 
PART II 
0 Q O Q 0 
O O 0 
Incorporation of Pyruvate-2-140 into Blood Blucose 
of Intact Rats O O D D O D O O D O O O D O D D D O O C- 0 D 0 




Injection., " • o ., o o ,, o o o o a " " " o • • " " " o o o o 40 
V 
LIST OF ILLUSTRATIONS 
PART I 
Figu.re Page 
1o Glutamate-Symmetrical Intermediate Pathwa3 for 
P;yrrQlidine Ring Biosynthesiso o o o o o o o o o o o o o o o 3 
' 14 Glutamate Labeling.Patterns from CO2 o o o o o o o o o o o o 16 
3o Possible Pyrrolidine RingLa.belingPatternso ., o o o o o o o o 19 
PART II 
1o Blood Glucose Levels after Gluoagon Administration 
as a Function of Timeo o o o o o o o o o o o o o o o o o o o 35 
2o Blood Glucose Response to Varying Levels of Glucagon" o o o o 36 
vi 
PART I 
STUDIES ON THE CONVERSION OF CARBON-14 DIOXIDE 




Prior to 1964, information pertaining to the pathways of synthesis 
of alkaloids in tobacco plants had been obtained almost exclusively 
through potential precursor feeding (a general term for administering 
dif ferent compounds, not iµcluding CO2). Supported by the results of 
experiments with ornithine-2-14c (1,2), putrescine-1,4-14c (3 ), and 
glutamic acid-2-14c (4), Leete (5), in 1956, proposed the glutamate-
symmetrical intermediate hypothesis which has been the generally accept-
ed concept for the biosynthesis of the pyrrolidine ring of nicotine 
(Figure 1). Cyclization of the 6 -semialdehyde (I), which can be ob-
tained from either glutamic . acid or ornithine, yields ~ 1-pyrroline-
' 
5-carboxylic acid (II) which decarboxylates forming the symmetrical an-
ion (III~. Incorporation of glutamate-5-14c into this anion would then 
result in equal labeling of the pyrrolidine ring of nicotine at the C~2' 
and C-5' positions. Alternatively, ornithine can .be decarboxylated to 
putrescine which can then cyclize· to (IV); however, the incorporation · 
of putrescine is only 25% that of ornithine ( 6 ) • 
. . ~I 
Leete's hypothesis ( 5) has also received support from results ob-
tained from the administration of 2-, 3-, and 4-carbon precursors such 
as acetate, glycerol, propionate and aspartate. When aoetate-1-14c was 
administered hydroponically to intact Nicotiana rustica and the plants 
2 
I• I ) 
glutamic acid 
J ( 
CH2--cH2 I · I 







Figure 1. Glutamate-Symmetrical Intermediate 
Pa.thw~ for Pyrrolidine Ring 
Biosynthesis 
4 
were allowed to metabolize the isotope for 168 hours, the C-2' and C-5' 
positions ,of the pyrrolidine ring of the nicotine contained equivalent 
amounts of 14c, and the total 14c in these two carbons represented 95% 
of the 14c in the pyrrelidine ring ,( 7 ). , Reducing the metabolism period 
to 3 and 6 hours did not alter th~ percentage of 14c in C-2' (C-5' was 
not isolated). The administration of propionate~3-14c r~sulted in 
labeling patterns identical to those found with acetate-1-14c, indicat-
ing that tobacco plants metabolize propionate via acetate, probably 
along the j9 -oxidation pa thwccy- reported by Giovanelli and Stumpf ( 8 ) • 
I 
Similarly, glycerol-2-14c administration yielded 38% of the 14c located 
in carbon 2 of the pyrrolidin~ ring after 168 hours; shortening the in-
corporation time to 2 hours increased the amount of 14c in C-2' to 5o%. 
Wu et !d:,.(7) assumed an equal percentage of radioactivity in C-5'• These 
-=- -
results would be compatible with the metabolism of glycerol-2-14c 
through the glycolytic pathwccy-- to pyruvate-2-14c and to acetate-1-14c . 
Administering pyruvate-2-14c has also been shown to yield nicotine in 
which 40-5o% of the activity .of the pyrrolidine ring was present at 
C-2' ( 9) • 
Four carbon intermedia~es such as aspartic acid-3-14c, fumarate-2-
• I . , 
14c and succinate-2-14c were incorporated over ext~nded periods into 
nicotine with about 25~ of the activity in the pyrrolidine ring at C-2' 
as would be expected by the operation of the tricarboxylic acid cycle 
(7,9). 
Acetate-2-14c, and preeursors of acetate-2-14c such as glycerol-
' ' 
1,3-14c, propionate-2-140 and alanine-3-14c, have produced labeling 
patterns which are difficult to explain without invoking experimental 
error. After the incorporation of acetate-2-14c into Nicotiana rustica 
5 
plants over a period of 168 hours, carbon 2 of the pyrrolidine ring con-
tained 14% of the 14c in the pyr~olidine ring, presumably leaving by 
difference 72% in carbons 3 and 4; however, reducing the incorporation 
period to 2 hours increased the amount of 14c in C-2' to 20%, leaving 
'·I 
6o% in carbons 3 and 4 ( 7 ). A shorter, incorporation period, however, 
should reduqe the peraentage of, 14c in carbons 2 and 5 by reducing the 
number of turns of the tricarboxylic acid cycle and thus reducing the 
amount of randomization occurring. 
In addition, other precursors gave labeling patterns in nicotine 
inconsistent with those predicted by the tricarboxylic acid cycle and 
Leete's hypothesis. Among these precursors are: succinate-1-14c and 
citrate-1-14c which should result in about 5o% of the activity in the 
pyrr~lidine ring at C-2' , as with acetate-1-14c; however, with succinate-
1-14c, only 15% of the activity was loqate~ at C-2' of the pyrrolidine 
ring ( 9 ). With citrate-1-14c only 3% of the activity was located at 
C-2' ( 9 ). Also, glucose-1-14c and glucose-6-14c, which, via the gly-
colytic pathwa;y, should both yield acetate-2-14c, in fact, produced 19% 
and 4%, respectively, at carbon 2 of the pyrrolidine ring ( 9 ). 
These discrepancies (7 ,9) descri bed above have not been resolved 
although it has been theorized (10) ~hat the pathwa;ys which led to the 
above labeling patterns are aberrant pathwa;ys stimulated by deviations 
from the natural growth conditions of the planto Rapoport~ alo (11) 
have studied the differences found in the labeling patterns of the pyr-
rolidine ring of nicotine with potential precursor feedings and with 
exposures to normal levels of 14co2• Working with relatively short time 
exposures (2 to 12 hours) of Nicotiana glutinosa to 14co2, they found a 
! 
very low percentage of 14c, varying from 0.3% to 3.8%, located in C-2' 
6 
of the pyrrolidine ring, a result w~ich does not conform to the gluta-
mate-symmetrical interm~diate hypothesis, using known glutamate biosyn-
theses ( 11 ). The incorp.oration of 14co~ via the carbon reduction cycle 
would result in glucose-6-phosphate uniformly labeled in all carbons 
. ' 
after ten minutes .; with shorter time periods, carbons 3 and 4 would con-
tain equal activity and relatively more activity than carbons 1, 2, 5, 
and 6, also equally labeled (12). This would yield, after ten minutes, 
pyruvate and acetate equally labeled in all carbons, and would result in 
equal amounts of activity in all c&;rbons of the pyrrolidine ring of 
nicotine; however, a low perqentage of activity at C-2' implies a low 
percentage at C-5', i f a glutamate-symmetrical intermediate is accepted, 
leaving th~ remainder, about 94%, divided between positions 3 and 4 of 
the pyrrolidine ring. Further degradations were done (10) to determine 
the 14c present in C-2' and C-3' and, by difference, C-4' and C-5'• 
These analyses yielded about 2% of the total nicotine activity in C-2' 
and in .C-3~ with 0-4'+c-5' containing 13%• Assuming C-2' • 0-5', C-4' 
wou·ld then contain almost five times as much aotivi ty , as ~ of the 
other carbons of the pyrrolidine ring, a reault which could not support 
the glutamate~s;rmmetrical intermediate hypothesis. The species dif-
fer~nce between Rapoport's wor~ wit4 002 and Niootiana glutinosa and the 
earlier feeding experiments with ornithine-2-14c and Niootiana rustioa 
were nullified by feeding ornithine-2-14c l ,to !• glutinos~ plants and 
finding an equal quantity of label at C-2' and C-5' of the pyrrolidine 
ring of nicotine (10). The most significant oonolusion drawn by 
I • 
Rapoport and his group (10) from these degradations is that the label-
ing pattern in the pyrrolid~ne rin~ obtained from precursor feedings 
via & symmetrioal intermediate could re1ult from a minor or aberrant 
pathwa.;r of niootine bio81'nthesis, sinoe the 14co2 exposures are repre-
' 
sentative of normal growth conditions. 
- ' 
Furt~ermore, no known pathwa.;rs of glutainate biosrnthesis from co2 
oo~ld e;xplain such a labeling pattern. In fact, much speoulatiGn had 
been voiced by Rapoport and his group ( 6) concerning the biosynthetic 
pathwa.;rs of glutam;o aoid, even to the point of proposing a hypotheti-
cal pathwa.;r of glutamate biosynthesis to account for a glutamate label-
ed primarily in carbon 3 involving the condensation of equally labeled 
glyoolic acid and acetate via malate synthetase to form ma.late which 
then participates, without randomization, in all the trioarbo:x:;ylic acid 
cycle reaction~ yielding oL-ketogluta.rate labeled only in position 3. 
Their more recent degradations, however, ehowing the greatest percentage 
of activity to be at q-4' ruled out "ijle above possibility. The prob-
lem I of· PART I of this thesis is concerned with· the determination' of ; .. 
the labeling patterns in the glutamie acid of ~obaooo plants. following 
14co2 exposure since no experimental work had been done along these 
lines in this system .. 
CHAPI'ER II 
EXPERIMENTAL 
' A. Isolation Procedures 
Pots containing 3 to 5 Nicotiana rustica 1• plants, 1 month old, 
were prepared and kept in growth chambers under constant conditions 
(12 hour day, 86°F, 100% humidity) for at least a week prior to these 
experiments. A biosynthe~ic chamber was used of approximately 2 liters 
in vol ume, fitted with a sidearm in which the radioisotope was placed 
and a socket for a Geiger-Muller . tube . A Geiger-Muller tube connected 
to a count-rate meter with a recorder monitored the level of isotope 
present in the chambero The plants, one pot per experiment, were ex-
posed to 100).lC of 14c-labeled carbon dioxide released from 0.326 mg of 
labeled sodium bicarbonate in water (400_,uc/ml; 2508 mc/mmole, purchas-
ed as a dry powder from Nuclear-Chicago) by the addition of 1 ml of 12 N 
H2so4• This i ntroduced Oo095 ml of 14co2, an increase of Oo005% above 
the atmospheric level of 0.03%. A very slight vacuum was drawn in the 
chamber and an equilibration period of 21 minutes and 5 minutes (for the 
long and short illumination periods, respectively) was allowed for the 
isotope to diffuse throu~h the chambero All of the above procedures 
were done in the dark and in the early morning, 6:00 A.M. to 8:00 A.M., 
since the plants had become accustomed to light illumination beginning 
i n the growth chambers at around these times. The plants were then il-
luminated for either 18 or 3 minutes with 2 Sylvania "Gro-Lux" lamps 
8 
9 
positioned vertically on either side of the bios;ynthetio ohamber and 1 
Westinghouse 150V Reflector Spot fastened above the chamber. At the 
end of the illumination period, the chamber was swept in the dark with 
room air for 33 minutes and 6 minutes (for the long and short illumina-
tion periods, respectively) into 1 N NaOH scrubbers. The plants were 
then removed from the chamber a.nd the leaves were pla.oed in liquid 
nitrogen within one minute of the time of removal from the chamber. 
The free amino acids were extracted.from the leaves by the method of 
Zelitoh (13)o Olutamio and a.spartie acids were isolated from t.lie crude 
. extracts by ion-exchange chromatography using a 1.5 :x 20 cm Dowex 1x8, 
acetate oolumn as described by O'Neal ud ~oeppe (1,4). A ninhy-drin 
ass~ was used to determine the amount of amino acid present (15). Av-
erages of 1.6 and 1o4.)lffloles per g of leaf tissue of glutamate a.nd as-
partate, .respectively, were obtained. 
B. Counting Techniques 
All liquid samples, i.e., the orude extracts. of the leaves and the 
amino acid fractions eluted from the eol~, were counted using a Tri-
Carb Se;t"ies 30.00 Liquid Scintillation Spectrometero Br~'s solution 
was used as a scintillation fluid (16)0 Bao~ound under these condi-
tions averages 25 opm with an efficiency of about 53% as deterntined by 
correlation with the wet combustion of the diluted, crystallized samples ... 
Samples were counted for a sufficient. time such that 99% of the samples 
had an error of less than ±1%0 
All glutamio and aspartio a.cid samples were diluted with nonradio-
active amino aoid to a workable speoifib aoti vity ( 1 O to 20 rgµ.o/mmole) · 
in such quantity as to allow complete degradation (at least 2.5 mmoles). 
Weighed a.mounts of these crystalline samples were combusted in a. wet 
10 
combustion-vibrating reed apparatus (17) to determine the specific 
activity of the sampleo Recrystallization was continued until a oon-
stant specific activity was obtainedo 
C. Degradation Procedures 
The degradation scheme for glutamio acid was carried out by the 
method of Mos.bach et al. (18) as modified by Koeppe and Hill (19)o -- . 
Aspartic acid was deoarboxylated with ninb;rdrin in the wet combustion-
vibrating reed apparatus (17)0 
CHAPTER III 
RESULTS. •AND .. DISC:~ISSIOll . 
The significant features of the e::x:perimenta.l results (Table I) are: 
A. The labelit;i.g of· C-4 a.nd·c-5 werenea.rly equa.l, as were C-2 
and 0-3; 
B. The labeling of 0-4 + C-5 wa.s alwqs muoh larger than 0-2 
+ C-3;. 
c. :he labeling of c-1_ was a.lwqs higher than C-2 or C-3; 
D. Shortening the exposure time ~eatly increased the percent 
labeling in C-4 and C-5 at the exper:i.se of the 0th.er three carbons of 
I 
glutamate, and increased the percent of radioactivity incorporated into 
the earboxyl carbons of aspartate; 
E •. The ratio of the specific aotivity of glutamate to the 
specific activity of aspartate increased as the exposure time increased. 
Points A and B indicate that~ equally labeled 2-carbon source, 
such as acetate, is the main preqursor of carbons 4 and 5 of glutamio 
. ' 
acid.. If such is the case, the srna.ller amo~t of, a.o-t7-vi ty equally dis-
tributed between 0~2 and 0-3 of glutamate would be the natural result of 
the randomization of C-4 and C-5 through suooinate and fumara.te by each 
turn of the tricarboxylio acid cycle. 0-1 would also acquire activity 
.. 
__ by this procedure. Point D then emphasizes the above sta.te~ent since 
shortening the exposure time would reduce the amount of randomization 
that would occur, thereb7 increasing the ,percentage of activity in 0-4 
111 
TABLE I 
LABELING IN LEAF AMINO ACIDS OF NICOTIANA RUSTICA !!• AFTER EXPOSURE TO 14co2 
Amino Acid L"D"ht li:Ynosu~e Time - ~ min. Lisrht ii?rnosure Time - 18 min-
.JJ.curies/ per cent ,,.ncuries/ per cent ~curies/ per cent .,)J.Curies/ per cent 
· mmole of total mmole of total mmole of ,total mmole of total 
Glutamic acid 
Total 1.76 0.54 . 14.3 39.1 
Carbon 1, COOH 9.1* >20.0* 30.4 32.0 
Carbon 2, CHNH2 .. 1.9 < 1.0 7 .1 10.3 
Carbon 3, CH2 2.3 < ·1.0 7.6 11.0 
Carbon 4, CH6 40.8 38.0 25.3 21.1 Carbon 5, CO H 45.8 40.4 27.4 21.8 
Aspartic acid 
Total 3.86 1.62 15.4 58.5 
Carbon 1 + 4, COOH 79.9 92.4 75.8 70.6 
* by difference 
~ 
""" 
and C-5 at the expense o.f the other three, carbons of glutamate. The 
high ratio of activity in 0-1 to .C-2 + C-3 in glutamate and the high 
I 
earbox,;yl labeling in aspartate, both decreasi;ng somewhat with time, can 
be explained by continuous 14co2 fixati~n into ox~laoetate and a some-
~hat slower formation of symme-:t;rioally labeled pyruvate via the carbon 
reduction cycle. ,Point E, indioati~g that the specific activity of the 
glutamate. increases relative to the speoifiQ activity of the aspartate, 
may reflect a difference in the turnover·rates of the two metabolic 
pools. 
These data are not compatible with the following routes of gluta-
mat~ biosynthesis (Table II): 
Ao The glyo::icylate-malate, proposal by Al worth !.! !:!.• ( o ); 
B. The reductive reversal of the tricarbo.Jcy"li'c acid cycle 
ppstulated to occur in Chlorobium thiosulfatophilum (20); 
c. The reversal of glutamate fermentation in Clostridium 
teta.nomorphum (21,22) and·in Acetobaoter su.bop:dans (23); 
D. T~e synthesis of glutamate in Clostridium kl:g.yveri (24)0 
.The formation e>f equally labeled acetate. can be explained by the 
.carbon reduction pathway (25) and,, assuming that the glya~late formed 
in Nicotiana. rustica as a.result of 11co2 fi,xa.tion is.r1,1.pia.J.y.~abeled~ 
then Table II shows that none of the above glutamate biosyntheses will 
• • • , •• f 
give a lab.eling pattern such· that C-4 • C-5, C-2 • ~-3, anci ~4 'and C-5 
will contain more, 110,tivi ty ,than 0-2 and c-3. Pathway A would produce 
a:·,glutamate .labeled m2µnly in C-3; B .would yield··0-3 • c ... 4 as wouldhO 
' ' ' 
and D. 
The; incorporation of' equally .labeled acetate ;obt~ned .from: the ii 
oarbon.,reduotion cycle into glutamate via. the normal operation ,0£~ the 
, ~- ' •,•. • ':I"'\ : ' • I ,, 
TABLE II 
DERIVATION OF GLUTAMATE CARBON ATOMS 
Pa.thwa3" 
GlyoJty-late-ma.late proposal (6) 
ChlorobillIIJ ~thtosJ.11fatophilum (20) 
The citrama.late pathwa3" (21-23) 
Clostridium kluyyeri (24) 
a a-r = acetate, C-1 
b a-2 = acetate, C-2 



















d CO2 = carbon derived from co2 fixation such as pyruvate C-1 and oxalacetate c--1 and C-4 
e p-2,3 = pyruvate, C-2 and C-3 
,.j, 
.(:,,,, 
tricarbo:xylic acid cycle, along with the fixation of 14co2 to form 
oxalacetate, would yield the labeling pattern observed (Figure 2)o Re-
f erring to the work of Calvin and Bassham (25) on the carbon reduction 
cycle, with 14co2 as a r~ioactive carbon source, after a 5.4 second 
exposure, the carbons of fruptose ~ave the following labeling: C-1, 3%; 
C-2, 3%; C-3, 43%; C-4, 42%; C-5, 3%; C-6, J{o. After a 10 minute ex-
posure , glucose-6-phosphate has th~ following labeling pattern: C-1, 
17%; C-2, 16%; C-3, 19%; C-4, 22%; 1C-5, 13%; C-6, 13% , (12)o By Ernbden-
Meyerhof glycolysis, carbons 3 and 4 become C-1 of pyruvate which is 
subsequently lost by decarbo:x:ylation to acet_ate. Carbons 1 and 6 of the 
hexose become carbon 2 of acetate, and carbo~s 2 and 5 become carbon 1 
of acetate. Thus, af ter a metabolism period of 10 minutes, the acetate 
entering the tricarbo:xylic acid cycle should 9e equally labeled. 
According to Calvin and Bassham (25), the carbo:xylation by which 
phosphoglyceric acid is formed does not require cofactors derived from 
light energy, but the re~ction by which phosphoglyceric acid is reduced 
to triose phosphate is a reaction which does require such cofactors. 
The reservoirs of these cofactors are presumed to be so small that the 
supply is exhausted very soon a~ter the light is turned off. Thus, the 
reaction by which phosphoglyceric acid is reduced would stop soon after 
the light is turned off, but the reaction by which phosphoglyceric acid 
is formed (the carbo:xydismutase system) would continue until the supply 
of CO2 acceptor is exhausted. The shortest metabolism period used in 
these experiments is 3 minutes in the light and 6 minutes in the dark, 
a reaction period which possibly would not yield equally labeled acetate 
via the carbon reduction pathwaJ7 (it maJ7 be, of course, that the equal 
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Figure 2. Glutamate Labeling Patterns from 14co2 
.... 
'O"i 
shorter time periods than 10 minutes). 
Without ATP and NADPH (26), the metabolism of phosphoglyceric acid 
(PGA) · proceeds predominantly by the following- alternate routes (25 ) : 
3-PGA-1-140~ 2-PGA-1-140--> phosphoenolpyruvate-1-140 f 14co 
14 14 2 glutamate-1- CI.-- oxalacetate-1,4- C 
The great er percentage of activity in C-1 of glutamate as compared to 
C-2 and C-3 following 14co2 exposures could be a result of the dark re-
action of phosphoglyceric acid-1-140 leading to glutamate-1-1400 The 
label in C-1 of gl utamate would be derived from the fixed 14co 
2 
rather than from the phosphoglyceric acid-1-14c. 
Other biosynthetic pathways which could account for the labeling 
pa t terns observed utilize glycolate as a precursor. The rapid formation 
of symmetrically labeled glycolate, a reaction known to oc.cur in tobacco 
plants (13), and its subsequent metabolism via glyo:xylate, glycine, ser-
ine , and pyruvate yield almost uniformly labeled pyruvate and, therefore, 
acetate (27 ) . The randomization of C-4 and C-5 of glutamate derived 
f rom acetate would produce labeling in C-2 and C-3 as observed. In ad-
dition , Sekizawa ~ al. (28) have studied an enzymatic condensation of 
glyo:xylate with oxalacetate in Acetobacter suboxYdans which could ex-
plain these data by the conversion of symmetrically labeled glycolate to 
glutamate via glyo:xylate, ox,almalate, ~ -hydroxy, "Y-ketoglutarate and 
o(.-ketoglutarate. The first three carbons of oxalacetate, formed from 
pyruvate derived from the carbon reductio~ cycle and 14co2, would be 
. ' 
labeled more slowly than glyo:xylate, thus accounting for the observed in-
crease with time of c-2+c-3/c-4+c-5. The formation of o(._ -ketoglutarate 
from glyo:xylate and pyruvate via Y -hydro:xy, ~ -ketoglutarate is another 
18 
possibility and would account for C-1 containing more activity than C-2 · 
or c-3. Some evidence for the formation of' r~bydro:xy, o(.-ketogluta.r-
a. te in plan ts ha.~ been recorded (29, 30 ) • 
In a recent paper containing an improved nicotine degradation 
' 
method, ~apoport and his group (31) found carbons .. 4 and 5 of the pyrrol-
idine ring to. contain almost equal amounts of label. C-2' consistently 
contained low levels of incorporation, i.e., 1.3"/o to 3.3% as compared. to 
13% for C-4 + C-5'• C-3' was variable, sometimes equaling C-2' and a.t 
times equaling C-4', depending upon the metabolic conditions. These re-
sults led them to indicate an involvement of glycolateo 
' , I , 
Recent work by Kisaki .!1.!l• (32) has indicated an involvement of' 
Y -methylaminobutyraldehyde as ~ precursor of the pyrrolidine ring and 
· the methyl group of niooti.ne. This finq.ing implies a new pathwa;r with a 
new set of precursors for the biosynthesis of the pyrrolidine ring of 
While the work of th~s tkesis can.no~ be directly applied to the 
problem of nicotine biosynth,esis1,. some;oonclusions regarding possible 
. labeling patterns can,, be drawn. If gl~tama.te is an· intermediate j,n pyr-
• ' I I 
rolidine ring biosynthesis from ~4co2, and if a symmetrical intermediate 
is involved as has been proposed in the conversion of glutamate to ,he 
pyrrolidine ring, all carbons in the pyrrolidine ring should be equally 
labeled. If no symmetrical intermediate exists, then the predicted la-
beling would be C-2' = C-3.' and C-4' = C-5'. (Figure 3). Low speoi,:fio 
14 ... 
activity in the nicotine isolated from CO2-exposed plants a.nd low 
1cooperative efforts wiiih Dro Ro U. Byerrum and Horst Zelke of 
Michigan State Univers~ty are now beins made to correlate the nicotine 
and glutamio a.eid labeling patterns in Nicotiana plants exposed .to 
14002 and fed potential precursors. ·. ' 
yields in the steps &f nicotine degradations ha.ve hampered accuracy in 
' I 
thi~ a.rea., and improvements a.r~ cqnstantly being sought. If, indeed, 
'i4co2 is found, with improved nicotine degradation schemes, to give un-
symmetrical labeling in the pyrrolidine ring, then a pa.thwa.Y of pyrroli-
dine ring biosynthesis involving neither glutamate nor a glutamate-sym-
metrical intermediate must be invoked. 
*CH--· CH *** I 2 I 2 
COOH / *0~/,9H *** 
I / N{9 
*CHNH2 symmetrical I intermediate 
*CH -I 2 
***CH · &__;C~CH2*** 
1
2~ · I· I 
*:**COOH . no :.symmetrical C a~ OH *** "!01 . /2 intermediate __ __.,/ -Jr' 
,H .CH CH 
~NI· . 3 · 
Figure 3 •. PQssible Pyrrolidine Rin;.Labeling Patterns 
CHAPTER IV 
SUMMARY 
When one month old Niootia.na rustica l!o plants were exposed to 
14co2 for 3 and 18 minutes in the light, degradations of the free 
glutamio acid isolated from the leaves pro4uced the following re~ults: 
1. The labeling of C-4 and C-5 were nearly equal, as were C-2 and 
2. The labeling of C-4 + C-5 was alwqs much larger than C-2 + C-3; 
3. The labeling of C-1 was alwqs higher than C-2 or C-3; 
4. Shortening the exposure time greatly increased the per cent 
labeling in C-4 and C-5 at the expense of the other three carbons of 
glutamate,. 
These data can be explained by the normal operation of the carbon 
reduction and tricar'boxylic acid cycles and indicate that if the pyr-
rolidine ring of nicotine is formed from a symmetrical intermediate de-
rived from glutamic acid via ~ 1 -pyrroli~e-5-carboxylic acid, then all 
the carbons in the pyrrolidine ring should be equally labeled. If, how-
ever, no symmetrical intermediate exists in this pathway, formation of 
the pyrrolidine ring from glutamio acid should yield C-2' = C-3' and 
C-4' = C-5'• 
A SELECTED BIELIOGRAPHY 
(1) Leete, E., Chemistry and Industry,.537 (1955). 
(2) Dewey, L. J., Byerrum, R. U., and Ball, C. D., Bioah±pto .!U,.Biot>h.vs. 
Acta., ~,. 141 ( 1955) o 
(3) Leete, E., l..• Amo~ • .§.2.2.o, .§2., 2162 (1958),-
(4}. Lamberts, Bo L .. , andByerrwn; R. TJ., l..• fil..s?!• Chem., fil, 939 
· (1958). · 
(5). Leete, E., l.• Afil• ~. ~., 1§., 3520 (1956). 
(6) Alworth, w. L., Liebman, Ao A., and Rapoport, Ho, l..• Am.• Chem • 
.§22., ,S6, 3375 (1964). · 
(7) Wu, P. L .. , Griffith, To, and Byerrum, R. u., l..• fil..s?! .. .Qh!mo, fil, 
. 887 (1962). . .. · · . 
(8) Giovanelli, J., and Stumpf, Po K., i!..• Biol • .Qh!m .. , ill, 411 (1958). 
(9) Christman, D. R. 9 and Dawson, R .. F •. , Biochemistry;, Z., 182 (1963). 
(10) Liebman, A. A., Morsingh, F., and Rapoport; H., l..• Am,o ~. Soo., 
fil, 4399 ( 1965). . · . 
(11) Alworth, W. L .. , De Selma, R. c., an(;i Rapoport, H., l..• Am.• .Qbm. 
' I ~ 0 f .§&, 1608 ( 1964) 0 ' 
(12) Havir, E. A., and Gibbs, M .. , l..•~• ~., 2~8, 3183 (1963). 
(13) Zelitoh, I., l..• fil..s?!o Qh.!m.o, 240, .1869 (1965). 
(14) O'Neal, R. M., and Koeppe, R. E., i!..• Neuroohem., ll, 835 (1966). 
(15) Rosen, H., ~. Bioche~ .. ~iophyso, §1, 10 (1957). 
(16) Bray, G. A.,~. Biochem., 1, 279 (1960). 
(17) Van Slyke, Do D., and Foloh, J., i!..• Biol • .Q.b!m., .1i€, 509 (1940); 
Van Slyke, D. D., Pla.zin, J., and Weisiger, J. R., ibid., 
ill, 299 ( 1951) 0 
(18) Mosbaoh, Eo H., Phares, E. F., and Carson, s. R., A:£Qh• l3ioohem .. 
Bioph.ys., .ll, 179 (1951). 
(19) Koeppe, R. E., and-·i;Iill,, R. J., ~· ~. £he•, 216, 813 (1-955). 
(20) Evans; M. c. w., :B"®hanan, B. B., and Amon, D. F., lm.2;.: l[&i. 
~· M•, 55., ,2s (1966). , - -
(2i) l/J.!unoh=Petersen-;· A., and Barker; H. A., l• ~. Qhmn.; 2.3.Q., 649 
(1958). - - -
22 
(22) :Barker, H. A., Smyth, R. D., Wawszkiewioz, E. J., Lee, M. N., and 
Wilson, R. M., Arch. :Biochem. Bi9ph.ys., 1!2, 468 (1958). 
-· 
(23) Ma.ragoilda.kis, M. E.,_ Sekizawa, Y., King1.T. E., and Cheldelin, 
V. H. , Bioohemistr:y, .5., 2646 ( 1966 J• i -
(24) Tomlinson, No, ;r,. Biol. Chemo, 209, 605 (1954)0 
£· 
(25) Bassham, J. A., and Calvin, M., "The Path of' CarboainPhotosyn-
__ thesis", Prentice-Hall, Ino., New Yo.rk, N .. Y., .. 1957 .. 
(26) These commonly used abbreviations are defined in: l• Biol .. Chem., 
~. 4 (1967). 
(27) Sinha., s. K .. , and Cossins, Eo A., :Bioohem. l•, ,2,§,, 254 (1965). 
(28) Sekizawa., Y., Maragouda.kis, M. E.1 King., T. Eo; and Cheldelin, 
V. H. , Biochemistry:, .5., ,2392 ( 1966). ' 
(29) PaJ7es; B., and La.ties, Go Go, Bioohemo Bioph.ys, Res. Commun., ll, 
. · ,. · 179 (1963). · 
(30) Kuratomi, K., and Fukunaga, ·Kot Bioohim. JU Bioph.ys. ·Aota, Al, 562 
( 1960). · ' 
(31) Liebman, A. A., Mundy, :a. P., and-Rapoport, H., l.• Am, .. Chem .. Soo., 
.§2, 664 ( 1967). 
(32) Kisald,.1 T., Mizusaki, s., _and Tamaki, E., ~' Bioohem. l3ioph.ys., 
l.11, 677 (1966). 
PART II 
STUDIES ON THE HORMONAL CONTROL OF 
PYRUVA,:'E-2-14c METABOLISM 




In the mammal, the liver and the kid~ey cortex are the main sites 
where amino acids and other precursors can· be converted to carbohydrate. 
Although the enzymatic sequences involved in gluconeogenesis have been 
well documented, the control of this very ~mportant biosynthetic path-
way is not well understood despite voluminous material on the subject 
(1-3). Depression of gluconeogenesis apparently occurs dur~ng ingestion 
of carbohydrate and with an insufficient suppl~ of adrenocorticosteroids. 
Enhancement of the pathwccy- follows fasting and diabetic conditions and 
' . 
the administration of adrenal cortical hormones. The ·magnitude of the 
effects of the above conditions and their. si.te of action or mechanism 
have yet to be elucidated. 
There is much support for the proposal (4) that steroid hormones 
affect the enzyme-forming system so as to increase the a.mount of certain 
enzymes (5-13). Presumably the glucocorticoid hormones affect the 
enzymes involved in amino acid degradation and gluconeogenesis. Of par-
ticular interest here, phosphoenolpyruvate oarboxy.kinase (EC 4.1.1-32), 
a pacemaker in gluconeogenesis and the enzyme responsible for convert-
ing oxalaoetate to phosphoenolpyruvate, bas been shown to respond to 
adrenooortical hormone administration (14-16). In adrenalectomized rats, 
cortisone and hydrooortisone, at a dose of 10 mg per dS3' for 5 dS3's, 
24 
increased the activity of this enzyme 2.5 fold (16). This enhanced 
activity is apparently the result of new enzyme synthesis since it can 
be abolished entirely by puromycin or actinomycin D (1 4,1 7). Two find-
i ngs , however, are in disagreement: one , the increased activity of 
phosphoenolpyruvate carbo:xykinase is discernible only long after the 
early phys i ological effect of the adrenal corticoids on glucose forma-
tion is known to occur, and, two, Ray~ al. (17) have found that hydro-
cortisone stimulated liver glycogen deposition in normal and adrenal-
ectomized rats even though enzyme induction was prevented by actinomycin 
D. There must be, then, primary effects other than enzyme induction. 
I n addi tion to the above, adrenalectomized rats when fasted exhibit the 
same increase in phosphoenolpyruvate carbo:xykinase as do normal rats, 
indicating that the adrenal corticoids are not necessary for the en-
hancement of activity (16)o Ray~ al. (17) concluded that the adreno-
cortical hormones are neither the exclusive inducers nor do they act 
permissively with respect to enhancement caused by fasting; it is more 
probable that the hormones have some other effect which is amplified 
through a variety of metabolic influences until finally enzyme synthe-
sis is increased. Other investigators have reached the same conclusion 
(18-20). 
Other treatments have included fasting for 48 hours, which increases 
phosphoenolpyruvate carbo:xykinase activity 3 fold above the activity of 
a normal fed animal (16). It is particularly interesting that refeed-
ing a mixed diet restores the level to normal while refeeding diets 
containing fat, casein, vitamins and minerals but no carbohydrate result 
in even further enhancement of the enzyme's acti-yity (16). Adding 
sucrose back to this synthetic diet serves to restore the enzyme activity 
26 
to normal. Glucose or glycerol alone given orally also result in the 
same effect , but serine , alanine and .2-deo:xyglucose do not. From these 
data it could be reasoned that glucose or glucose derivatives serve to 
• I 
repress the phosphoenolpyruvate carbo:xykinase system; however, this 
must not be the case, since in the diabetic rat, the abundant supply of 
glucose is not effective in reducing the activity of the enzyme. In 
fact, in alloxan-diabetic rats, the enzyme levels are 6 fold that of 
normal (16). Temporary diabetes produced by mannoheptulose also in-
creases the enzyme levels rapidly, to 3 fold that of a normal rat after 
4 hours; pancreatectomy results in levels 2.5 fold that of normal. In-
sulin administration r apidly depresses the increased levels of this 
enzyme in the alloxan-diabetic animal although it has little or no 
effect on the normal animal. Lardy ll al.(16) feel that the more likely 
acti.on is that the metabolite which depresses phosphoenolpyruvate 
carbo:xykinase activity is formed from glucose but only in the presence 
of insulin • 
. It should be noted that a coincident pacemaker step along with the 
conv~rsion of oxalacetate to phosphoenolpyruvate is the carbo:xylation 
of pyruvate to oxalacetate by pyruvate carbo:xylase (EC 6.4.1.1), an 
enzyme known to be under the feedback control of acetyl. CoA (1); how-
ever, while phosphoenolpyruvate carbo:xykinase activity is influenced 
greatly by glucocorticoid administration, in fasting and in di~betes, 
pyruvate carbo:xylase in the mitochondria in unaffected (1,21). These 
findings have been challenged by Henning ll al. (22) who have found 
pyruvate carbo:xylase activity in the cytoplasm in sufficient quantity 
to cover the gluconeogenic capacity of rat liver; their data shows this 
enzyme to be activated by starvation and alloxan diabetes although the 
stimulation is relatively low compared to that of phosphoenolpyruvate 
carbo::xykinase. 
Extensive work has been done previously in attempts to correlate 
various animal treatments and conditions with the labeling patterns in 
glutamic acid in hope of using this method to demonstrate a shift in 
pyruvate metabolism (23, 24). This compound has been shown to be use-
ful in studying the metabolism of carbo::xyl and bicarbonate compounds in 
intact rats (25). Labeling patterns in glutamate maJ" be indicative of 
the relative amounts of pyruvate converted to acetate and to oxalacetate 
since acetyl CoA is the precursor of carbons 4 and 5 of glutamate (via 
o<..-ketoglutarate ) and oxalacetate is the precursor of carbons 1, 2, and 
3 of glutamate. It is well established in mammalian systems that 
acetate-1-14c will label only C-1 and C-5 of glutamic acid (23,26-28). 
Thus, if the decarbo::xylation of pyruvate is the predominant metabolic 
reaction, a large portion of the labeling from pyruvate-2-14c will be 
found in C-5 of glutamate. If, however, gluconeogenesis is accelerated 
and pyruvate is mainly carbo::xylated to oxalacetate, relatively little 
activity will be found in C-5 of glutamate from pyruvate-2-14c and most 
of this activity will be found at positions 2 and 3 after randomization 
in fumarate. Koeppe~~. (23) have shown that in a normal fed rat 
given pyruva~e-2-14c, about 38% of the total activity in the liver 
glutamic acid is located in carbon 5. On the other hand, fasting for 
48 hours reduced this percentage to about 3%, reflecting the shift i n 
pyruvate metabolism. The mechanism of this shift and its precise con-
trol have· not yet been explained. 
The administration of bydrocortisone and 9-o( -fluoroprednisolone, 
both adrenocorticoids, to normal fed rats followed by injection of pyru-
2~ 
vat e-2-14c 4 and 24 hours l ater, resulted in 35% of the total activity 
i n the liver gl ut amate located at carbon 5, results which are s imilar to 
those obtai ned i n a normal f ed cont rol (24 ), . Al loxan diabe t es of short 
duration (8 to 14 da3"s ) reduced the percentage of total activity located 
at C- 5 to 5%• Prol onging the alloxan diabetes to 6 weeks, however , re-
turned the l abel ing pattern to a normal 35% in C-5 (23). This differ-
ence i s yet to be explained. Feeding a high fat diet in order to stim-
ulate pyruvate carboxylase through i~creased levels of acetyl CoA re-
sulted i n 13% in C-5 (24). Severe thiamine deficiency which should im-
pair the decarboxylation of pyruvate to acetyl CoA did not alter the 
relative amount s of pyruvate metabolized via acetyl CoA compared to the 
amounts metaboli zed via oxalacetate as indicated by the labeling patterns 
in glutamate from a t hiamine deficient animal and a normal control (24). 
In addi tion to the above treatments, one which became of interest 
concer ned the effect of glucagon on the metabolism of pyruvate. Perhaps 
the most s t riking physiological effect of glucagon administration to a 
well-fed animal is the very rapid rise in blood sugar (29). It is gen-
erally accepted that thi s abrupt elevation is due to the activation of 
l iver phosphorylase , an effect mediated by adenosine-3',5'-phosphate 
(cyclic AMP ) which ,is formed by the interaction of glucagon with the 
membrane-bound adenylate cyclase system (30). Glucagon not only stimu-
l ates gl ycogenol ysi s, but it has also been found to increase the rate of 
glucose synthesis from 3-carbon precursors (31-33). While this mechan-
ism has not been cl early defined, glucagon has recently been shown to 
have a direct lipolytic action on liver which ma3" help to explain its 
gluconeogeni c activity (34). Increased hepatic lipolysis with the con-
current enhanced availability of free fatty acids results in a rise in 
29 
fatty acyl CoA and acetyl CoA levels. Elevation of acetyl CoA levels 
serve to activate pyruvate carbo:xylase and thus perhaps stimulate gluco-
neogenesis. Also, Lardy and his group (1 4) have previously found eleva-
tions in phosphoenolpyruvate kinase activity after glucagon administra-
tion. A purpose of PART II of this thesis is to test the magnitude of 
t his effect as reflected in the labeling patterns in liver glutamate 
following glucagon and pyruvate-2-14c injection. 
Further work done by the author in cooperation with Dr. s. K. 
Meghal concerning mannoheptulose is also contained in this thesis. 
Mannoheptulose is a seven carbon .sugar . found in large concentrations in 
t he avacado, which has been shown to cause severe hyperglycemia of sev-
eral hours duration in the rat, and to cause a diabetes-like syndrome, 
characterized by hyperglycemia, glucosuria and an increase in ketone 
bodies (35). It has been postulated that these phenomena resulting from 
mannoheptulose administration are brought about by the impairment of 
glucose utilization and by an increase in glucose production (36). 
Further , mannoheptulose is thought to exert its effect by blocking the 
release of insulin from t~e ~ -cells of the pancreas (14)o Since 
Shrago et al.(14) have reported increases in phosphoenolpyruvate car-
bo:xykinase of 2 fold after mannoheptulose administration, it was also 
of interest to determine the effect of this compound on pyruvate meta-
bolism as reflected in the labeling of q-5 of glutamic acido 
CHAPTER II 
EXPERIMENTAL 
A .. Isolation and Assa.y.2.f. Blood Glucog;e 
. r 1. , : 
An attempt was made to determine blood glucose specific activity 
after isotope injection using the method of Friedmann £1 .!:1,o (37); 
Amberlite MB3 mixed-bed resin was put in the sodium bicarbonate.form by 
I ' 
:slurrying it with 6 vol um.es of. 0.,9 N sodi~ bicarbonate. until all the 
ea;rbon dioxide was evolved; this slurrying process was repeated twiceo 
A column, 1o9 x 30 om 9 was pa.eked and washed with 2 liters of Oo9 N 
sodium bioarbonateo The resin was then stored in Oo9 N sodium bicarbon-
ate and refrigerated until neE!dedo Small columnsp Oo8 x 20 cm 9 were then 
packed and washed with water until the c9nduoti~tyof th~ effluent was 
' ' 
within 10 tihtes that of the wash watero The purpose of such a column was 
to remove possible radioa.cti ve i.onized metabolites 11 partioulary · the in-. ' . . 
jected pyruvate 9 from the blood glucose sampleo Preliminary tests with 
.unlabeled glucose and pyruvate-2-140 indicated that some radioactive com-
pound was passing through the column and was being eluted in the same 
fractions as the gluooseo Fractions taken off the column (1 ml ea.ch) 
~ere counted in scintillation via.ls containing 15 ml BraJT 0 s solution (3e) 
and Oo5 ml water in the Tri-Carb Series 3000 Liquid Scintillation Speo-
trometero Analyses showed 008% of the isotope placed ~n the column was 
recovered from fractions 3-100 Pa.per chromatography in n-butanol: 95% 
; ' 
ethanol: Oo5 M NH40H (7i1 :2) on W.ha·tma.n Noo 1 of the dinitrophel!Yl-
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hydrazine derivatives of the py~vate sample used (one which was stored 
lyophilized in 0.'1'/o NaCl under nitrogen for 1 year) yielded 1o7% of the 
total pyruvate activity present in parapyruvate and 100% present at the 
origin of the chromatogram (unidentified) • .It was felt that perhaps one 
of these contaminants was passing through the .column., Corresponda.nce 
with Dr. Sidney Weinhouse (January 10 1 1967) revealed that they had en-
countered the same difficulty, but they felt that the maximum degree of 
contamination was low with respect to the conversion that they were 
mea.suringo This would be valid provided we were measuring differences 
in incorporation into glucose comparable to those between fed and fasted 
animals which vary from 1e0)lc/mmole in a fed rat to 28o4)1o/mmole in a 
fasted rat (Table I); however, the change in the amount incorporated af-
ter the administration of gluca.gon is not as pronounced, and since a 
high degree of accuracy was desired, a modification of the osazone deri-
vative method of Steele ,!1 ,!!o (39) was a.doptedo The modification con-
sisted of making the glucosazone from the. glucose sample taken off the 
MB3 column rather than making the derivative directly from the blood 
filtrateo For comparison purposes, specific activities were still de-
termined directly from the column glucose sample by the following pro-
cedure: a measured quantity of blood, usu.ally 1 tp 2 ml, was deprotein-
ized with 1o% Znso4 and Oo5 N NaOH according to the method of Somogyi 
(40), and 5 ml aliquots were passed through a colupm. o.f MB3 r~sin as de-. 
scribed aboveo The eluate plus water washings was ma.de to 10o0 ml with 
water, and 0 .. 5 ml aliquots were used for ra.dioa.otivity measurements in 
the Tri-Carb Series 3000 Liquid Scintillation Spectrometer as described 
for the amino acids in PART Io Another sample was used for glucose de-
termination with the Glucostat (Worthington Biochemical Company) using 
reaction conditions of 37° for 30 minuteso The remainder of the sample 
was used to make a glucosazone derivative which was then combusted a.nd 
counted in the wet combustion-vibrating reed apparatus referenced in 
PART L, Specific activities of blood glucose determined by the gluco,sa-
zone method ranged from 14% to 38% lower than thor6e determined directly 
from the column glucose sample .. A chromatogram of' a glucose sample off 
the column run in n-butanol: acetic acid: water (4:1:5) on Whatma.n No. 1 
yielded activity at the glucose position and at the origin (unidentified)o 
Bo Animal Experiments 
1o Changes in Blood Glucose Levels with Glucagon Administration 
Solutions of 1 mg/ml were prepared by dissolving a weighed 
amount ( 1 mg at a time) of cr,.ysta.lline glucagon, (lot noo 126B-0440, 
Sigma Chemical Company) in water at pH 2o5 with HClo These solutions 
were kept at 5°, and the glucagen remains in ,solution with ma:x:im'Um sta-
bility under these conditions ~or 1 year (41). Aqdition of a solution 
' . ' 
0.05 Min KCl, however, would rapidly and irreversibly denature it ... A 
blood dilution pipet was calibrated to contain 0 .. 044 ml of blood and ~as 
used whenever small blood samples were neededo In order to determine 
the variation in blood glucose ,.levels after glucagon administration, 3 
young male Holtzmann rats (175-250 g) were usedo A $tock Purina diet and 
water were fed ·.s!!! libtt'Umo All animals were used in the early morning to 
insure afed,cond:htion., The rats were injected intraperitoneally with 
varying amounts of the gluca.gon solution, and blood. samples were taken 
from nicks in a tail vein onto a heparinized slide at five minute inter-
vals for 40 minutes. A device employed to immobilize the animals while 
the samples were being taken consisted essentially of 2 hinged sponges, 
between which the rats were restrained, mounted on a small platform (42)., 
The blood samples were deproteinized according to the microtechnique of 
Somogyi (40), a.nd Glucostat assa;ys wer~ run in duplicate on each sample 
to determine the a.R1ount of glucose present. Each rat served as its own 
control, the same procedure being used after the intraperitoneal injec-
tion of a solution of water at pH 2o5 with HClo 
2~ Isotope Experiments 
Young male albino rats, as above, were used (203-290 g) and 
were maintained under the same conditions unless specified, as in Table 
I where fasting conditions were imposeq for 48 hours upon two a.nimalso . . 
Gluoagon (2 mg/kg; 1 mg/ml) was given intraperitoneally 15 minutes a.nd 
3 hours prior to the injection, also intraperitoneal, of sodium pyruvate-
2-14c in 0.9% NaCl (10 mc/mmole, purchased lyop~ilized from Nuclear-
Chioago)o D-mannoheptulose, a.,gift from Dro Nelson Rioh~er, National 
Institutes of Heal th, Bethesda., Maryland,. was given subcu;ta.neously ( 600 
mg per rat in water) followed by sodium pyruvate-2-14c, injected intra-
peritoneally, 1 a.nd 4 hours latero The animals were allowed to metabol-
ize the isotope for 12 mi.nuteso They were then stunned and their throats 
out; the blood was collected in a beaker treated with a very small a-
mount of 1o% potassium oxalate and was deproteinized.within5 minutes of 
exsanguination as described in Part A of CHAPTER IIo The liver was re-
moved, blo.tted on filter pa.per and froz.e:n in liquid nitrogen. The free 
gluta.mio a.nd aspartio acids were isolated as described by O'Neal a.nd 
Koeppe (43)0 The rats were considered fed if. their stomachs still oon-
tained food upon post-mortem examination. 
I 
c. Counting Techniques and Degradation Procedures 
The counting techniques and degradation procedures for the amino 
.,aids are identical to those de.s.Gribed .and referenced in PART. I. 
CHAPTER III . 
RESULTS AND DISCUSSION 
Figure 1 demonstrates the rapid rise in blood glucose levels after 
the intraperitoneal injection of glucagon (1 mg/kg). In all animals a 
fairly constant maximum level was achieved at about 30 minutes after in-
jection, although the initial response appears to be characteristic of 
each animal. Other workers have also noted this 30 minutes period neces-
sary for maximum effect after glucagon administration (34,44)0 Increas-
ing the dose to 2 mg/kg resulted in a linear increase in the blood sugar 
level with no significant alteration in the length of time in which the 
peak .level of blood glucose was obtained (Figure 2)o The rate .of fall 
of the glucose level after its,peak rise was much more rapid with the 
increased doseo It is interesting to note that the stress plaoed upon 
each of the rats.by restrain~ng them every 5 minutes for a period of 40 
minutes in an apparatus specifically designed for tai1 vein injection in 
order to remove a tail vein blood sample elicited a ri~e in blood sugar 
of 33 :I: 1.3%. Such stress probably boosted the peak blood sugar levels 
and undoubtedly affected the initial slope of the curveso 
The occurrence of enhanced gluconeogenesis after glucagon ad.minis-
tration to. rats in vivo has been d~monstrated by the incorporation of 
increased .amounts of 14C-bica.rbonate into plasma glucose (45). Gluoagon 
has been shown to,produce a five fold increase of 14c-glucose production 
after 30 minutes (46) •. As can be seen in Table I, fasted rats incor-
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Figure 1. Blood Glucose Levels after Glucagon Administration as 
a Function of Time 
Rats were given gluoagon (1 mg/kg) intraperitoneally, and blood 
samples were taken from a tail vein at 5 minute intervals as 
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Figure 2. Blood Glucose Response to.Varying Levels of Glucagon 
porate greatly increased amounts of pyruvate-2-140 as compared to fed 
rats$ The blood glucose specific activity sho~ld then be indicative of 
the amount of pyruvate that is converted to glucose and thus should cor-
relate with the percentage of labeling in c-5 of glutamate. In using 
h,yperglycemic agents, the total amount of incorporation into gluco.se 
should be considered since the increased rate of glucose production may 
result in dilution of the isotope due to an increased glucose pool size. 
As is shown in Table I, the total incorporation of activity into 
.glucose in 100 ml of blood from pyruvate-2-140 in a fasted rat was a-
bout 10 times the incorporation into the blood glucose of a fed rat. 
Administering glucagon 15 minutes before the injection of the isotope 
increased the amount of incorporation somewhat, while 3 hours after glu-· 
cagon treatment, the total incorporation of activity into the glucose in 
100 ml of blood resembled that of a normal fed control. Mannoheptulose 
administration had an immediate effect as well as a long-lasting effect; 
the amounts of incorporation after 1 and 4 hours were similar and more 
than doubled the total incorporation into blood glucose obtained with 
glucagon. The fact that mannoheptulose retains its effectiveness in 
this respect even after 4 hours may indicate not only an inhibition of 
insulin release from the pancreas but also an impairment of insulin 
synthesis by this compound as has been proposed by Moskalewski (47). 
By allowing the rats to met~bolize the isotope for a duration of 
12 minutes, 15 minutes ~fter the injection of glucagon, it was hoped to 
determine whether the rapid production of new glucose at this point was 
a result of gluconeogenesis, which would yield glutamate with a very low 
per cent labeling in C-5, or whether the new gluoose was derived from 
glycogenolysis, which would result in high labeling in C-5 of glutamateo 
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TABLE I 
, INCORPORATION OF PYRUVATE-2-14c INTO BLOOD GLUCOSE OF INTACT RATS 
'-·~- - ====·-- Amount of 1 Blood Glucose 
Rat Treatment, Pyruvate-2- 4c mg/ Spec. Act., po/ 
Number Time Injected,_)).c 100ml pc/mrnole 100ml 
324 Fed 11.0 104 1 .o 0.58 
326 Fed 25.0 99 2.2 1 .21 
325 Fasted, 21.0 90 27,,6 13.79 
48hours 
327 Fasted; 21 .. 0 66 28.4 10.41 
48 houvs 
328 Glucagon, 21.0 230 1.3 1 .. 66 
15 m:iinutes 
329 Glueagon, 22.,0 113 2.7 1.68 
15 minutes 
330 Gluoagon, 21.5 109 2 .. 3 1.39 
3 hours 
335 Glucagon, 21.0 99 2.1 1016 
3 hours 
331 Mannoheptulose, 22 .. 8 339 2.1 4.00 
1 hour 
332 Mannoheptulose, 22.8 134 5 .. 4 4.02 
4 hours 
ADJ degre.e of cooperation between .these pathwqs should moderate the re-
sults between these two extremes. Further work was also done on rats 
given gluca.gon 3 hours prior to pyruvate-2-14c injection since Shrago 
~~~ (14) have found a 2.5 fold increase of phosphoenolpyruvate ear-
boxykinase activity above normal 3 hours after giving gluoa.gon. If this 
enzyme is indeed pertinent to the control of gluooneogenesis and is re-
latively more a.ctivetthen a shift in labeling from high C-5 to lower C-5 
in glutamate would be observed. A summary of the results is given in 
Table II~ The labeling patterns found in both the 15 minutes and 3 hours 
experiments resemble those of normal fed ra.ts. This would seem to indi-
oate the predominance of glycogenolysis over gluooneogenesis in the ef-
feet of gluoa.gon; howevert it can be assumed that a slight increase in 
. ' . 
gluooneogenesis occurred as shown in the incorporation of more activity 
into blood glucose 15 minutes after glucagon ad.ministration. The high 
labeling in C-5 of glutamate probably indicates that this method utiliz-
ing glutamate labeling patterns is not .sensitive enough tQ reflect small 
changes in the relative routes of pyruvate metabolism. 
I 
Mannoheptulose, on the other hand, exerts a profound effect upon 
the labeling in glutamate. The per cent labeling found in C-5 was 8%, 
both 1 and 4 hours after its administration. The effect upon pyruvate 
metabolism is clearly seen after 1 hour although the rise in phosphoenol-
pyruvate carbo:x;ykinase aotivity is less than the l'.ise in activity fol-
lowing glucagon administration after 3 hours, which did not alter the 
amount of .labeling in C-5 of glutal'flate as compared to a normal fed rat. 
Predictably, these data indicate that factors other than changes in phos-
phaenolpyruvate carboJcy"kinase activity are responsible for the differ-
,noes in the labeling of C-5 of glut~ate and implicate insulin in the 
4:0 
T.Al3LE II 
LABELING PATTERNS IN LIVER GLUTAMATE AFTER PYRUVATE-2-14c INJECTION . . 
Amount of 1 Distribution of C in G uta'mate 
Ra.t Treatment, Pyruvate-2- 4c Spec.Act., Per Cent of Activity 
Number Time Injeoted,.)l.C ..)lc/mmole c-1 C-2+0-3 c-4 C-5 
324 Fed* 11.0 3.1 18 34 1.9 47 
326 Fed* 25.0 3.7 17 34 
325 Fasted,* 21.0 11.2 7 94 0.2 2 
48 hours 
327 Fasted,* 21.0 3.3 6 88 0.2 2 
.48 hours 
328 Gluca.gon, 21 .o 6.2 11 26 o.a 45 
15 minutes 
329 Gluoagon, 22.0 3.0 63 37 
15 minutes 
330 Gluca.gon, 21.5 2.9 17 42 3. 1 39 
3 hours 
335 Glucagon, 21.0 6.7 64 32 
3 hours 
\.. 
331 Ma.nnoheptulose, 22.8 6.2 87 8 
1 hour 
332 Ma.nnoheptulose, 22.8 5 .. 2 91 9 
4 hours 
* S. K. Me~, personal communication. 
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control of this pathway. 
In two ,glucagon-treated a.nill)als the percentage of activity in C-4 
was also determined. Work by Greenba1.1m ~ .!l• (48) has shown that the 
NAD<}/NADH ratio .in the liver of glucagon-treated rats rose from the con-
trol value of 3.6 to. 5o0. The response of the NAD+/NADH ratio to vari-
ous treatments is significant since, while liver mi to.chondria carboxy-
late pyruvate to form OJl'.alacetate, the latter does not diffuse through 
the membrane, and, instead, must be either converted to citrate, trans-
aminated to form aspartate, or reduced by NADH to ma.late, all of which 
can diffuse from the mitochondria. In gluconeogenesis, ma.late in -:!;he 
©ytoplasm must be oxidized by NAD+, and the oxalacetate produced con-
verted to phosphoenolpyruvate. In the oytosol1 the ratio NAD+/NADH 
would be lowered by the relative conversion of more ma.late to oxalace-
tate; conversely, if more oxalacetate is reduced to ma.late, prior to the 
conversion of this'ma.lat~.tQ oxala.ceta.te and then·to citrate in the 
mi tochondria.1 mhe ratio NAD+ /NADH would be increased •. ,,.Im/the oytosol 
of a fed rat the concentration of NAD+ is almost 9 times that of ·NADH.;" 
in a rat fasted for 24 hours, however, the ratio NAD+/NADH drops to 4o5, 
indicat±ng a. shift tc:>-.the oxidation or ma.late to oxala.ceta.te in p,repara-
tion for the oo:za.version of oxa.la.oetate to phosphoenolpyruvateand then 
to glucose (49). •If pyruvate-2-14c were metabolized via o:x:alacetate, 
ma.late, •·and,randomized in fuma.ra1;e in the tricarboxylic,aoid cycle·of 
the mitochondria and,then converted back to phosphoenolpyruvate via ma.-
late ~d o:xa.la.cetate in the cytosol, the cytoplasmic phosphoenolpyruvate 
would be labeled in both carbon 2 and carbon 3. Metabolism. of thi,s 
1cytosol ~s defined (49) as the cytoplasm minus the.mitochondria 
and endoplasmic reticulum·components. 
intermediate to pyruvate and then to acetate would result in acetate 
labeled in both C-1 and C-2 with the amount of labeling in C-2 being 
p~op©~tional to the amount of pyruvate traversing such a pathwa.r~ Sino~ 
0-2 ©f acetate is the precursor of C-4 of glutamate, the amount of activ-
i'ty in C-:4 of glutamate as compared to the amount in C-5 may reflect this 
m~t~bolic route~ although C-2 of oxalacetate also labels C-4 of glutamate 
' + 
after one turn of the tricarbo:xylic acid cycle .. The ~elative dominance 
of this pathway could either control or be c~ntrolled by the ratio of 
NAD+ to NADH since the greater the amount of oxidizing power available, 
the more malate can be converted to oxalacetate, and,conversely, the more 
m,®,l©l,te converted to oxa.lacetate, the higher the concentration of NADHo 
The data presented here indicate no significant change from the results 
with a normal fed rat, which has about 2% in C-4 of glutamate as compar-
ed to about 35% in C-5 (23), indicating that, after glucagon treatment, 
the formation of doubly labeled acetyl CoA derived from oxalaceta.te that 
had equilibrated w;i.thfumarate is not a~celerated. 
It seems more likely, then, as indicated by the data presented 
here, that the primary source of the new glucose produced by the injec-
tion of gluca.gon is the breakdown of glycogen rather than increased 
gluconeogenesis. While gluconeogenesis may be very slightly accelerated, 
this increase is too small to be detected by a reduction in the amount 
of radioactivity incorporated into C-5 of glutamate from pyruvate-2-1400 
Since the blockage of insulin,release by ma.nnoheptulose has been 
well documented ( 14), the eff.eot of mannoheptulose is probably be.st de-
fined as a. la.ck of insulin, which results in a diabetic state with all 
the concurrent symp,toms, including severe hyperglyoemiao Although the 
effect of mannoheptulose is not permanent, the duration of the syndrome 
following a single injection suggests a more severe effect such a.s im-




When glucagon and ma.nnoheptulose were given to normal fed rats 
prior to the injection of pyruvate-2-140, the following results were 
obtained: 
1. The hyperglycemio effect of one intraperitoneal injection of 
glucagon was immediate, and blood glucose reached a ~eak level in about 
30 minutes after injection; 
2. Gluca.gon did not alter the labeling pattern found in the free 
liver glutamio acid either 15 minutes or 3 hours after injection as com-
pared to a normal fed control; 
3. Mannoheptulose reduced the per cent of activity in C-5 of free 
liver glutamio acid about four fold as compared to a normal fed rat, 
both 1 hour and 4 hours after injection; 
4. Ma.nnoheptulose more than doubled the amount of pyruvate-2-140 
incorporated into blood glucose as compared to a normal fed control, 
while glucagon only very slightly increased the amount. of isotope in-
corporated into blood gluoose over that of a normal fed rat. 
These data indicate that the primary source of the new glucose pro-
duced after gluoagon injection is glyoogenolys±s rather than increased 
gluooneogenesis, and that, 'based upon comparisons with other studies, the 
effect of mannoheptulose is probably best described as insulin insuf-
ficiency. 
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APPENDIX A 
BLOOD GLUCOSE LEVELS PRIOR TO TERMINATION OF EXPERIMENTS 
' ' 
Rat Rat '11rea.tment, Blood Gluoose, mg/100ml 
Number Weight Time Pre-injeo.tion 15 mi.n. 30 min. 
328 203 Gluoa.gon, 116 168 
15 minutes 
329 211 Gluoagon, 116 149 
15 minutes 
330 209 Gluoa.gon, 130 146 
3 hours 
335 204 Gluca,gc;,n; 123 150 141 
3 hours 
331 260 Mannohep·tulose, 135 
1 · hour 
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